Dynamic factors affecting HPV-attributable fraction for head and neck cancers
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Current Opinion in Virology
- Vol. 39, 33-40
Abstract
No abstract availableKeywords
Funding Information
- Cancer Prevention and Research Institute of Texas
This publication has 54 references indexed in Scilit:
- Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck CancerJournal of Clinical Oncology, 2013
- Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa RicaPLOS ONE, 2013
- Towards the eradication of HPV infection through universal specific vaccinationBMC Public Health, 2013
- Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in EuropeBMC Cancer, 2013
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- HPV Vaccine against Anal HPV Infection and Anal Intraepithelial NeoplasiaNew England Journal of Medicine, 2011
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in MalesNew England Journal of Medicine, 2011
- Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance dataThe Lancet Infectious Diseases, 2011
- Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortiumInternational Journal of Epidemiology, 2009
- Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology ConsortiumCancer Epidemiology, Biomarkers & Prevention, 2009